Inspite of Preliminary skepticism, new advancements in peptide drug discovery have rejuvenated desire in peptides as therapeutic agents, with about 70 peptides currently marketed and several other Many others in clinical development. These techniques open up new avenues for treatment options personalized to overcome distinct breast cancer subtyp